An Exploratory Clinical Study of SHR6390 and SHR1020 in the Treatment of Esophageal Squamous Cell Carcinoma After Progression on PD-1 Antibody
Clinical trial NCT04866381 · UNKNOWN
Trial details
- NCT number
- NCT04866381
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-01
- Primary completion
- 2023-04-01
- Enrollment
- 87
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.